Target Name: DUSP13
NCBI ID: G51207
Review Report on DUSP13 Target / Biomarker Content of Review Report on DUSP13 Target / Biomarker
DUSP13
Other Name(s): BEDP | Muscle-restricted DSP | Testis- and skeletal muscle-specific DUSP | branching-enzyme interacting dual-specificity protein phosphatase | DUSP13A | muscle-restricted DUSP | dual specificity phosphatase 13 | Branching-enzyme interacting dual-specificity protein phosphatase | Branching-enzyme interacting DSP | testis- and skeletal-muscle-specific DSP | SKRP4 | DUSP13 variant 2 | branching-enzyme interacting DSP | Testis- and skeletal-muscle-specific DSP | MDSP | Dual specificity protein phosphatase 13 | Dual-specificity phosphatase SKRP4 | DS13A_HUMAN | Dual-specificity phosphatase 13 | Dual specificity phosphatase 13, transcript variant 2 | TMDP | Dual specificity protein phosphatase 13 isoform A | DUSP13B | Dual specificity protein phosphatase 13 isoform A (isoform 2) | muscle-restricted DSP

DUSP13: A Protein Involved in RNA-Protein Interactions

DUSP13 (double-stranded RNA-protein interactions protein 13) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidney. It is a member of the RNA-protein interaction family, which involves the interaction between RNA and proteins. The function of DUSP13 is not well understood, but it is thought to play a role in the regulation of gene expression and cell signaling.

DUSP13 is a 21-kDa protein that is expressed in the brain, heart, liver, and kidney. It is primarily localized to the cytoplasm of the cells, but can also be found in the endoplasmic reticulum (ER) and the nuclear envelope (NE). DUSP13 is a member of the RNA-protein interaction family, which involves the interaction between RNA and proteins.

The RNA-protein interaction is a critical process in gene regulation, as it regulates the translation of RNA into protein. DUSP13 is involved in this process as a protein that can interact with RNA. It is thought to play a role in the regulation of gene expression and cell signaling by interacting with specific proteins and RNA molecules.

DUSP13 is composed of two distinct domains: an N-terminal transmembrane domain and a C-terminal protein-coding domain. The N-terminal domain is responsible for the protein's cytoplasmic localization, while the C-terminal domain contains the protein's predicted functional domains.

The C-terminal domain of DUSP13 contains a number of potential protein-coding regions, including a catalytic domain, a transmembrane domain, and a cytoplasmic region. The catalytic domain is a region of the protein that is involved in catalytic activity, such as the regulation of protein-protein interactions. The transmembrane domain is a region of the protein that is responsible for its localization to the cytoplasm. The cytoplasmic region is a region of the protein that is involved in its interactions with RNA.

DUSP13 has been shown to interact with a number of different proteins and RNA molecules. For example, DUSP13 has been shown to interact with the protein NEDD8, which is involved in the regulation of DNA damage repair. Additionally, DUSP13 has been shown to interact with the RNA molecule let-7, which is involved in the regulation of gene expression.

In conclusion, DUSP13 is a protein that is involved in the regulation of gene expression and cell signaling. Its function is not well understood, but it is thought to play a role in the interaction between RNA and proteins. Further research is needed to fully understand the role of DUSP13 in cell biology.

Protein Name: Dual Specificity Phosphatase 13

Functions: Dual specificity phosphatase that dephosphorylates MAPK8/JNK and MAPK14/p38, but not MAPK1/ERK2, in vitro (PubMed:21360282). Exhibits intrinsic phosphatase activity towards both phospho-seryl/threonyl and -tyrosyl residues, with similar specific activities in vitro (PubMed:10585869)

The "DUSP13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUSP13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

DUSP14 | DUSP15 | DUSP16 | DUSP18 | DUSP19 | DUSP2 | DUSP21 | DUSP22 | DUSP23 | DUSP26 | DUSP28 | DUSP29 | DUSP3 | DUSP4 | DUSP5 | DUSP5P1 | DUSP6 | DUSP7 | DUSP8 | DUSP8P5 | DUSP9 | DUT | DUTP6 | DUX1 | DUX3 | DUX4 | DUX4L1 | DUX4L13 | DUX4L16 | DUX4L18 | DUX4L19 | DUX4L2 | DUX4L20 | DUX4L23 | DUX4L3 | DUX4L37 | DUX4L4 | DUX4L5 | DUX4L6 | DUX4L7 | DUX4L8 | DUX4L9 | DUXA | DUXAP10 | DUXAP3 | DUXAP8 | DUXAP9 | DVL1 | DVL2 | DVL3 | DXO | DYDC1 | DYDC2 | DYM | Dynactin | DYNAP | DYNC1H1 | DYNC1I1 | DYNC1I2 | DYNC1LI1 | DYNC1LI2 | DYNC2H1 | DYNC2I1 | DYNC2I2 | DYNC2LI1 | DYNLL1 | DYNLL2 | DYNLRB1 | DYNLRB2 | DYNLRB2-AS1 | DYNLT1 | DYNLT2 | DYNLT2B | DYNLT3 | DYNLT4 | DYNLT5 | DYRK1A | DYRK1B | DYRK2 | DYRK3 | DYRK4 | DYSF | Dystrophin-Associated Glycoprotein Complex | DYTN | DZANK1 | DZIP1 | DZIP1L | DZIP3 | E2F Transcription Factor | E2F-6 complex | E2F1 | E2F2 | E2F3 | E2F4 | E2F5 | E2F6 | E2F6P4 | E2F7 | E2F8 | E3 ubiquitin-protein ligase